Favorable outcome with sentinel lymph node biopsy alone after neoadjuvant chemotherapy in clinically node positive breast cancer at diagnosis: Turkish Multicentric NEOSENTI-TURK MF-18-02-study

Cabioglu, N.; Karanlik, H.; Yildirim, N.; Muslumanoglu, M.; Karadeniz, G. Cakmak; Can, D. Trabulus; Tukenmez, M.; Ersoy, Y. E.; Uras, C.; Zengel, B.; Emiroglu, S.; Polat, A. K.; Yeniay, L.; Ozkurt, E.; Kara, H.; Ibis, K.; Aydiner, A.; Ozmen, V; Igci, A.

doi:10.1016/j.ejso.2021.06.024

Favorable outcome with sentinel lymph node biopsy alone after neoadjuvant chemotherapy in clinically node positive breast cancer at diagnosis: Turkish Multicentric NEOSENTI-TURK MF-18-02-study

Date

2021

Authors

dc.identifier.doi

10.1016/j.ejso.2021.06.024

dc.identifier.other

WOS:000707020600006

Publisher

ELSEVIER SCI LTD

DOI

10.1016/j.ejso.2021.06.024

Keywords

Sentinel lymph node biopsy , Neoadjuvant chemotherapy , Local recurrence , Pathologic complete response , Isolated tumor cells , Micrometastasis

URI

https://openaccess.acibadem.edu.tr/handle/11443/7191

Collections

WOS

Full item page

Favorable outcome with sentinel lymph node biopsy alone after neoadjuvant chemotherapy in clinically node positive breast cancer at diagnosis: Turkish Multicentric NEOSENTI-TURK MF-18-02-study

Date

Authors

Journal Title

Journal ISSN

Volume Title

dc.identifier.issn

dc.identifier.doi

dc.identifier.other

dc.description.volume

dc.description.issue

Publisher

DOI

Abstract

Description

Keywords

Citation

URI

Collections

Endorsement

Review

Supplemented By

Referenced By